ANAESTHESIA TECHNIQUE Russian patent published in 2010 - IPC A61M21/00 A61M1/00 A61K31/277 A61K31/515 A61K31/13 A61K31/5517 A61K31/05 A61K31/4468 A61K35/14 A61K38/08 A61P23/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to anaesthesiology, and can be used as an anaesthesia care for surgeries, including oncotomy of various localisations. That is ensured by preoperative blood sampling in the amount 15 ml in a syringe with Solutio Glugicirum. Thereafter, dalargin 0.85 mcg/kg diluted in the same preservative is added in the syringe, and the prepared mixture is incubated at temperature 37°C for 30-35 minutes. Immediately before the induction, an anaesthetic is added with 1/3 dose of dalargin with autoblood and verapamil in dosage 0.9 mcg/kg. It is followed with the anaesthetic induction with thiopental sodium, ketamine, dormicum. Before the traumatic stage, 1/3 dose of dalargin with autoblood and verapamil in dosage 0.9 mcg/kg are introduced. The most traumatic stages require thiopental sodium, propofol, dormicum, phentanyl to be introduced. 30-40 minutes prior to the surgery completed, 1/3 dose of dalargin with autoblood are introduced in combination with actovegin in dosage 5.6 mg/kg.

EFFECT: technique enables adequate analgesia during the whole intra- and postoperative period combined with reduced dosage of the administered narcotic analgesics due to the optimised circulatory system, activated stress limit processes and normalised neurovegetative body functions.

2 tbl, 1 ex